%0 Journal Article %A Melissa Heightman %A Jai Prashar %A Toby E Hillman %A Michael Marks %A Rebecca Livingston %A Heidi A Ridsdale %A Kay Roy %A Robert Bell %A Michael Zandi %A Patricia McNamara %A Alisha Chauhan %A Emma Denneny %A Ronan Astin %A Helen Purcell %A Emily Attree %A Lyth Hishmeh %A Gordon Prescott %A Rebecca Evans %A Puja Mehta %A Ewen Brennan %A Jeremy S Brown %A Joanna Porter %A Sarah Logan %A Emma Wall %A Hakim-Moulay Dehbi %A Stephen Cone %A Amitava Banerjee %T Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals %D 2021 %R 10.1136/bmjresp-2021-001041 %J BMJ Open Respiratory Research %P e001041 %V 8 %N 1 %X Introduction Post-COVID-19 complications require simultaneous characterisation and management to plan policy and health system responses. We describe the 12-month experience of the first UK dedicated post-COVID-19 clinical service to include hospitalised and non-hospitalised patients.Methods In a single-centre, observational analysis, we report the demographics, symptoms, comorbidities, investigations, treatments, functional recovery, specialist referral and rehabilitation of 1325 individuals assessed at the University College London Hospitals post-COVID-19 service between April 2020 and April 2021, comparing by referral route: posthospitalised (PH), non-hospitalised (NH) and post emergency department (PED). Symptoms associated with poor recovery or inability to return to work full time were assessed using multivariable logistic regression.Results 1325 individuals were assessed (PH: 547, 41.3%; PED: 212, 16%; NH: 566, 42.7%). Compared with the PH and PED groups, the NH group were younger (median 44.6 (35.6–52.8) years vs 58.3 (47.0–67.7) years and 48.5 (39.4–55.7) years), more likely to be female (68.2%, 43.0% and 59.9%), less likely to be of ethnic minority (30.9%, 52.7% and 41.0%) or seen later after symptom onset (median (IQR): 194 (118–298) days, 69 (51–111) days and 76 (55–128) days; all p<0.0001). All groups had similar rates of onward specialist referral (NH 18.7%, PH 16.1% and PED 18.9%, p=0.452) and were more likely to require support for breathlessness (23.7%, 5.5% and 15.1%, p<0.001) and fatigue (17.8%, 4.8% and 8.0%, p<0.001). Hospitalised patients had higher rates of pulmonary emboli, persistent lung interstitial abnormalities and other organ impairment. 716 (54.0%) individuals reported <75% optimal health (median 70%, IQR 55%–85%). Less than half of employed individuals could return to work full time at first assessment.Conclusion Post-COVID-19 symptoms were significant in PH and NH patients, with significant ongoing healthcare needs and utilisation. Trials of interventions and patient-centred pathways for diagnostic and treatment approaches are urgently required.All data relevant to the study are included in the article or uploaded as supplementary information. %U https://bmjopenrespres.bmj.com/content/bmjresp/8/1/e001041.full.pdf